THE ROLE OF THROMBOSIS RISK SCALES LIKE PROGRESSION PREDICTORS OF COVID-19-ASSOCIATED PNEUMONIA.

Objective: The aim: To determine the risk factors for progression by establishing the diagnostic and prognostic role of PPS and ISTH DIC score in patients with COVID-19 required hospitalization.

Patients And Methods: Materials and methods: Main group was 130 patients with COVID-19, divided depending on the severity into 3 subgroups. Patients were examined twice.

A new perspective on bronchial asthma and chronic obstructive pulmonary disease overlap: potential diagnostic criteria.

Objective: The aim: The aim of the research was to analyze the results of observation andexamination of COPD patients in order to identify a group of individualswith potentialasthma overlap.

Patients And Methods: Materials and methods:We have conducted a two-stagedynamic investigation of 43 COPD patients during 3-8 years. The patients were divided into two groups: group 1 counted 30 individuals who presented with at least one episode of reversible bronchial obstruction (RBO) during the observation; group 2 - 13 individuals who presented with nonreversible bronchial obstruction (nonRBO).

Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

Objectives: To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates from community-acquired respiratory tract infections (CA-RTIs) collected in 2016-17 from Ukraine.

Methods: MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

Results: A total of 177 viable clinical isolates, including 78 S.

THE FORECAST OF LETHAL OUTCOME IN CHRONIC LEUKEMIA PATIENTS WITH PNEUMONIA.

The aim of the study - to create a mathematical model for forecasting of poor pneumonia outcome in patients with chronic leukemia in order to optimize treatment. Study included 323 patients with pneumonia and chronic leukemia. All indicators obtained in the study were entered into electronic database of formalized medical histories like a table "object-feature".

Diagnostic role of systemic inflammation, blood coagulation and padua prediction score in lung thrombosis risk estimation in hospitalized patients with community-acquired pneumonia.

Objective: Introduction: Some coagulation and thrombotic disorders during severe CAP could lead to some intravascular disorders and even be the reason of lethal end in hospitalized patients with CAP. But this fact hadn't been established to the end yet. The aim was to study the intravascular changes in patients with severe CAP and to estimate the role of parameters of systemic inflammation (procalcitonin (PCT), C-reactive protein (CRP)), blood coagulation test (fibrinogen, D-dimer, heparin time, prothrombin time) and risk of thrombosis in patients with moderate and severe CAP.